Current medical news and unique business news for anyone who cares about healthcare.
First umbilical cord blood product in U.S. The FDA approved its first umbilical cord blood product, Hemacord, for use in stem cell transplants for conditions including blood cancers and certain metabolic and immune system disorders. Hemacord is manufactured by the New York Blood Center. Cord blood is one of three sources of hematopoietic progenitor cells used in transplants. Those cells move into the bone marrow to replicate and mature, and once in the bloodstream, they can restore the number and function of many blood cells.
Tears for testing blood sugar. In the continuing hunt for easier, more efficient diabetes care, the American Chemical Society is reporting that scientists have seen success in testing a new sensor that measures blood glucose levels through tears, eliminating the need for finger pricks.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
China’s largest biotech goes public. China National Biotech Group is planning to raise up to $2 billion through a public offering in the first half of 2012, according to reports. It’s the fourth largest maker of vaccines and blood products in the world
More confusing data to feed your brain. Following some debate sparked by Wall Street Journal about the state of venture capital, Tech Crunch pulled some data from CrunchBase and found that we’re on track to see almost twice as many seed and angel deals this year as Series A deals. But that isn’t necessarily bad, one investor says…
New guidance from the FDA. On Thursday the FDA released two new draft guidances for studies in products under investigational device exemption. In the guidances, the regulatory agency allows studies to start earlier in the development process and clarifies its standards for approving trials.